Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Upgrade Now See Benefits

or

Already have an account? Log in here.

Should You Invest $1,000 in Denali Therapeutics Right Now?

Before you consider Denali Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Denali Therapeutics wasn't on the list.

While Denali Therapeutics currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Denali Therapeutics (DNLI)
3.7315 of 5 stars
$18.08-3.5%N/AN/AModerate Buy$35.71
Ultragenyx Pharmaceutical (RARE)
2.7324 of 5 stars
$15.90-1.1%N/AN/AHold$29.79
Sarepta Therapeutics (SRPT)
3.5203 of 5 stars
$15.13-5.8%N/AN/AHold$23.67
Pfizer (PFE)
3.5109 of 5 stars
$28.84-0.2%5.96%9.45Hold$30.32
Exelixis (EXEL)
2.252 of 5 stars
$67.10-2.8%N/A20.09Hold$58.62
Moderna (MRNA)
1.4061 of 5 stars
$215.27-3.6%N/AN/AHold$113.75
United Therapeutics (UTHR)
4.6325 of 5 stars
$587.88-0.6%N/A22.18Moderate Buy$676.40
Biogen (BIIB)
3.7017 of 5 stars
$251.65-0.7%N/A21.26Moderate Buy$254.41
Sanofi (SNY)
4.004 of 5 stars
$48.390.0%3.64%23.96Hold$53.00
Eli Lilly and Company (LLY)
3.5859 of 5 stars
$1,431.12-0.9%0.48%44.67Moderate Buy$1,422.00

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines